Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

NCT01623869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Adult Angiosarcoma
Recurrent Adult Soft Tissue Sarcoma
Stage III Adult Soft Tissue Sarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Trebananib

Sponsor

National Cancer Institute (NCI)